Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Clopieon 300
Clopieon 300 offers clopidogrel in 300 mg tablets, formulated to prevent cardiovascular events effectively.
Uses of Clopieon 300
Clopieon 300 is indicated for:
Prevention of heart attacks and strokes in patients with atherosclerosis, peripheral arterial disease, or a history of cardiovascular events
Reduction of the risk of blood clots in patients undergoing coronary stenting or angioplasty
Benefits of Clopieon 300
Potent antiplatelet activity to inhibit blood clot formation
Reduces the risk of thrombotic events such as myocardial infarction and ischemic stroke
Mechanism of Action of Clopieon 300
Clopidogrel in Clopieon 300 is a thienopyridine derivative that inhibits platelet aggregation by selectively and irreversibly binding to the P2Y12 receptor on platelets. This action blocks the ADP-mediated activation of glycoprotein IIb/IIIa receptors, thereby inhibiting platelet activation and aggregation.